Hi guys, PBT is my maiden Biotech stock, so excuse my inexperience in this question!
The fact that we have met our 100-patient target, and are looking at possibly adding more numbers, is this "the norm"? I mean, why do we need to put more people on the trial?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $136.9M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.5¢ | 1.2¢ | $659.0K | 45.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 3493344 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 600000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |